Skip to content
0:00 / 0:00

GLP-1 weight-loss drugs: What the science says | 90 Seconds w/ Lisa Kim

Stanford Medicine

150K subscribers • 21 videos on Rounds • Health institution

YouTube
  • Published by Stanford Medicine, one of the health institutions Rounds lists. Nobody has recommended it in the communities yet, so it ranks below community picks.
  • Presented by Sun Kim, MD, MS, as the video describes them

For anyone, no background needed. Education, not medical advice.

78K views4 months ago

NutritionHeart and metabolismGLP-1 drugsObesity and weightMetabolism and energy

Sun Kim, MD, MS, and Dan Azagury, MD, FACS, explain how GLP-1 medications work, their benefits, and potential risks.

With so much talk around GLP-1 medications and weight-loss drugs, how do you know if they're right for you? Stanford Medicine endocrinologist Sun Kim, MD, MS, and bariatric and minimally invasive surgeon Dan Azagury, MD, FACS, explain how GLP-1 medications work, who may or may not benefit from them, the potential benefits and risks, and why they're not a one-size-fits-all solution. Read more: stan.md/3SRKhHj . . . Stanford Medicine advances human health through world-class biomedical research, education and patient care. Bringing together the resources of Stanford University School of Medicine, Stanford Health Care and Lucile Packard Children's Hospital, Stanford Medicine is committed to training future leaders in biomedicine and translating the latest discoveries into new ways to prevent, diagnose and treat disease. The Stanford Medicine YouTube channel is a curated collection of contributions from our School of Medicine departments, divisions, students, and the community. Our diverse content includes coverage of events, presentations, lectures, and associated stories about the people of Stanford Medicine.

Why it's here

From a health institution

Stanford Medicine is on Rounds' list of health institutions, and this upload is one of its most-watched lectures or explainers. Nobody has recommended it in the communities yet, so it ranks below community picks.